Neurotoxicity in Primary Central Nervous System Lymphoma (PCNSL): An International Observational Study of Cognition in Long Term Survivors
Stopped early
Conditions studied: Primary Central Nervous System Lymphoma (PCNSL)
In brief
This research is being done to investigate cognition in long term survivors of Primary Central Nervous System Lymphoma (PCNSL). Sometimes caregivers as well as patients who no longer have the disease report cognitive problems such as reduced memory or attentional dysfunction and decreased quality of life. Unfortunately, little is known about what may contribute to this cognitive dysfunction in part because PCNSL is a rare disease and sensitive tests have not often been used in the research studies. This project is being conducted to help understand what factors, such as radiation, may contribute to cognitive dysfunction and better define the relationship between brain structure and thinking in people who have had PCNSL.
Key facts
- Study ID
- NCT00710151
- Run by
- OHSU Knight Cancer Institute
- People needed
- 80
- Starts
- 2008-07-01
- Expected to finish
- 2013-12-01
- Last updated by the study team
- 2017-04-21
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Radiological and histological diagnosis of PCNSL
- Age 18 years or older
- Survived 2 years or more following treatment
- Able to complete neuropsychological and neuroimaging parts of the study
- Signed a written informed consent in accordance with institutional guidelines
You may not qualify if…
- Subject has experienced recurrent disease
- Subject has a contraindication for MRI
- Subject has a contraindication for neuropsychological testing
- Subject has stage IV or V renal insufficiency
Where it is running
- Oregon Health & Science University — Portland, Oregon, United States
- Charite University Medicine — Berlin, Germany
- University of Bochum — Bochum, Germany
- University Medical Center — Freiburg im Breisgau, Germany
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.